title: Dose reconstruction of di(2-ethylhexyl) phthalate using a simple pharmacokinetic model.
abstract: BACKGROUND
  Di(2-ethylhexyl) phthalate (DEHP), used primarily as a plasticizer for polyvinyl chloride, is found in a variety of products. Previous studies have quantified human exposure by back calculating intakes based on DEHP metabolite concentrations in urine and by determining concentrations of DEHP in exposure media (e.g., air, food, dust).
  
  
  OBJECTIVE
  To better understand the timing and extent of DEHP exposure, we used a simple pharmacokinetic model to "reconstruct" the DEHP dose responsible for the presence of DEHP metabolites in urine.
  
  
  METHODS
  We analyzed urine samples from eight adults for four DEHP metabolites [mono(2-ethylhexyl) phthalate, mono(2-ethyl-5-hydroxyhexyl) phthalate, mono(2-ethyl-5-oxohexyl) phthalate, and mono(2-ethyl-5-carboxypentyl) phthalate]. Participants provided full volumes of all voids over 1 week and recorded the time of each void and information on diet, driving, and outdoor activities. Using a model previously calibrated on a single person self-dosed with DEHP in conjunction with the eight participants' data, we used a simple trial-and-error method to determine times and doses of DEHP that resulted in a best fit of predicted and observed urinary concentrations of the metabolites.
  
  
  RESULTS
  The average daily mean and median reconstructed DEHP doses were 10.9 and 5.0 µg/kg-day, respectively. The highest single modeled dose of 60 µg/kg occurred when one study participant reported consuming coffee and a bagel with egg and sausage that was purchased at a gas station. About two-thirds of all modeled intake events occurred near the time of reported food or beverage consumption. Twenty percent of the modeled DEHP exposure occurred between 2200 hours and 0500 hours.
  
  
  CONCLUSIONS
  Dose reconstruction using pharmacokinetic models-in conjunction with biomonitoring data, diary information, and other related data-can provide a powerful means to define timing, magnitude, and possible sources of exposure to a given contaminant.
authors.affiliation: Office of Research and Development, U.S. Environmental Protection Agency, Washington, DC, USA. lorber.matthew@epa.gov
authors.forename: Matthew
authors.initials: M
authors.lastname: Lorber
authors.forename: Antonia M
authors.initials: AM
authors.lastname: Calafat
mesh_terms: D000328:Adult; D004051:Diethylhexyl Phthalate / Q000493:pharmacokinetics / Q000652:urine*; D004305:Dose-Response Relationship, Drug; D004781:Environmental Exposure; D004784:Environmental Monitoring / Q000379:methods*; D004785:Environmental Pollutants / Q000493:pharmacokinetics / Q000652:urine*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008954:Models, Biological; D010968:Plasticizers / Q000378:metabolism* / Q000493:pharmacokinetics; D055815:Young Adult
chemical_list: D004785:Environmental Pollutants; D010968:Plasticizers; D004051:Diethylhexyl Phthalate